Company profile for LIfT Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

LIfT Biosciences is preclinical UK & EU based Biotech developing an innate allogeneic first-in-class neutrophil based cell therapy platform called N-LIfT (Neutrophil based Leukocyte Infusion Therapy). Our mission is to bring affordable curative therapies to patients with solid tumours with high unmet medical need, such as pancreatic cancer. The company was set up to develop a new type of adaptable cell therapy with a broad ...
LIfT Biosciences is preclinical UK & EU based Biotech developing an innate allogeneic first-in-class neutrophil based cell therapy platform called N-LIfT (Neutrophil based Leukocyte Infusion Therapy). Our mission is to bring affordable curative therapies to patients with solid tumours with high unmet medical need, such as pancreatic cancer. The company was set up to develop a new type of adaptable cell therapy with a broad killing mechanism that continues to kill even as the tumour adapts.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
London, England
Telephone
Telephone
+4408712261201
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/07/29/3122979/0/en/LIfT-BioSciences-announces-grant-of-12-million-from-Ireland-s-Disruptive-Technologies-Innovation-Fund-to-support-the-first-in-human-clinical-trial-of-LIfT-s-IMAN-therapy.html

GLOBENEWSWIRE
29 Jul 2025

https://www.globenewswire.com/news-release/2025/06/25/3104808/0/en/LIfT-BioSciences-Expands-U-S-Footprint-with-New-Facility-at-Portal-Innovations-Houston-Helix-Park.html

GLOBENEWSWIRE
25 Jun 2025

https://www.globenewswire.com/news-release/2025/06/04/3093304/0/en/LIfT-BioSciences-joins-Bayer-Co-Lab-Cambridge-securing-access-to-cutting-edge-lab-facilities.html

GLOBENEWSWIRE
04 Jun 2025

https://www.globenewswire.com/news-release/2025/05/22/3086286/0/en/LIfT-BioSciences-presents-preclinical-data-on-its-first-in-class-Immunomodulatory-Alpha-Neutrophils-at-American-Society-of-Gene-Cell-Therapy-28th-Annual-Meeting-showcasing-its-vers.html

GLOBENEWSWIRE
22 May 2025

https://www.globenewswire.com/news-release/2025/05/19/3083683/0/en/LIfT-BioSciences-presents-latest-data-on-its-first-in-class-Immunomodulatory-Alpha-Neutrophils-at-International-Society-for-Cell-and-Gene-Therapy.html

GLOBENEWSWIRE
19 May 2025

https://www.globenewswire.com/news-release/2025/04/28/3068895/0/en/LIfT-BioSciences-announces-partnership-with-University-of-Galway-for-clinical-trial-in-Ireland.html

GLOBENEWSWIRE
28 Apr 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty